Nicola Dagg > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Nicola Dagg
Work Department
Intellectual Property Litigation
Position
Nicola Dagg is a partner in the IP litigation team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas: (1) strategic life sciences patent and product lifecycle advice; (2) patent litigation; (3) co-ordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes. Nicola has tried over 20 cases.
Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global challenges.
Career
2018 to present Kirkland & Ellis International LLP; 2006-2018 Allen & Overy LLP; 1996-2006 Hogan Lovells
Education
Newnham College, University of Cambridge (M.A. Natural Sciences 1991); University of Bristol (Diploma in Intellectual Property Law and Practice 1997)
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Leading individuals)At Kirkland & Ellis International LLP, Nicola Dagg is the well-known head of the IP litigation team, while Emma Flett leads on technology and IP transactions. The group handles critical, high-stakes patent litigation for US and European big pharma and biotech companies. Flett’s expertise covers IP and technology transactions involving product acquisitions, licensing, R&D and supply and distribution agreements. She advises corporates and private equity houses. Litigator Jin Ooi has a pharmacology background and handles cross-border IP-related cases for a wide range of pharma clients. Katie Coltart is another key team member.
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
(Hall of Fame)‘Force to be reckoned with’ Nicola Dagg leads the rapidly expanding patent litigation practice at Kirkland & Ellis International LLP. Dagg, Daniel Lim and Katie Coltart have represented high-profile companies in the life sciences sector on market-defining patent trials before all levels of the UK courts, as well as handling parallel infringement proceedings concerning cutting-edge biotechnology innovations, and damages cases on behalf of global pharmaceuticals companies against generics companies. In the TMT space, Lim and Steven Baldwin are leading on major SEP and FRAND litigation proceedings for global telecoms corporations. Patent licensing disputes – including for the determination of royalty rates in the smartphones space – are also underway. ‘Powerhouse‘ partner Jin Ooi is another noteworthy name. The team also offers non-contentious commercial IP and collaboration advice.
Lawyer Rankings
- Hall of Fame - London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Leading individuals - London > Industry focus > Life sciences and healthcare
- Intellectual property: patents (contentious and non-contentious) - London > TMT (technology, media and telecoms)
- Life sciences and healthcare - London > Industry focus
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
Firm Rankings
- Corporate and commercial > Corporate tax
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Investment fund formation and management > Private funds (including infrastructure funds)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Real estate > Property finance
- Investment fund formation and management > Real estate funds
- Dispute resolution > Commercial litigation: premium